These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 309226)

  • 1. [Number of T and B-lymphocytes in the peripheral blood in rheumatoid arthritis relative to the disease activity, the serum immunoglobulin level and the drug therapy].
    Ströbel G; Dreher R
    Verh Dtsch Ges Rheumatol; 1978; 5():121-9. PubMed ID: 309226
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-immunological analysis of D-penicillamine use in rheumatoid arthritis].
    Benenson EV; Alibekova RI; Seĭsenbaev ASh; Cherkasskiĭ LA; Ivanova RL
    Vopr Revm; 1980; (4):27-31. PubMed ID: 6972667
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cellular immunity in rheumatoid arthritis. Effect of therapy].
    Roux H; Mercier P; Jeandel P; Brouillet-Gabriel M; Serratrice G
    Rev Rhum Mal Osteoartic; 1977 May; 44(5):331-4. PubMed ID: 329399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B lymphocyte function in patients with rheumatoid arthritis: impact of regulatory T lymphocytes and macrophages--modulation by antirheumatic drugs.
    Petersen J
    Dan Med Bull; 1988 Apr; 35(2):140-57. PubMed ID: 3282810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-penicillamine induced suppression of B cell function: in vivo effect of D-penicillamine.
    Lewins EG; Clancy RL; Cripps AW; Glass JS; Major GA
    J Rheumatol; 1985 Aug; 12(4):685-91. PubMed ID: 3877166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DNA-synthesizing lymphocytes in the blood of patients with disseminated lupus erythematosus, rheumatoid arthritis, and panarteritis nodosa (author's transl)].
    Huber C; Günther R; Michlmayr G; Huber H; Braunsteiner H
    Wien Klin Wochenschr; 1973 Feb; 85(6):92-5. PubMed ID: 4155172
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of Cuprenil (penicillamine) on peripheral blood lymphocytes and their T and B populations in patients with rheumatoid arthritis].
    Małdykowa H; Brühl W; Chwalińska-Sadowska H; Grabowska A; Cygler B; Dratwianka B; Abgarowicz T; Wierzchowska E
    Reumatologia; 1978; 16(4):509-13. PubMed ID: 310147
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of basic therapeutic procedures on the immunoregulatory T-cell apparatus in patients with chronic polyarthritis].
    Rautenstrauch H; Saal JG; Frank F; Laschner W
    Z Rheumatol; 1982; 41(1):23-5. PubMed ID: 6979136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The action of D-penicillamine on the distribution of T and B-lymphocytes in rheumatoid arthritis].
    Crouzet J; Fournier C; Bach JF; Camus JP
    Rev Rhum Mal Osteoartic; 1977 May; 44(5):335-7. PubMed ID: 329400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some immunological changes in rheumatoid arthritis among patients receiving penicillamine and gold.
    Huskisson EC; Berry H
    Postgrad Med J; 1974 Aug; 50 Suppl 2():59-61. PubMed ID: 4467180
    [No Abstract]   [Full Text] [Related]  

  • 11. Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis.
    Clegg DO; Ward JR
    Nurse Pract; 1987 Mar; 12(3):44, 49-52. PubMed ID: 2882451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of chrysotherapy on T-lymphocyte subpopulations in rheumatoid arthritis.
    Pfreundschuh M; Parino G; Gram N; Bröker A; Gause A; Hunstein W
    Z Rheumatol; 1983; 42(6):328-31. PubMed ID: 6229937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapy in the management of rheumatoid arthritis.
    Roumm A; Buckingham RB
    Compr Ther; 1983 Sep; 9(9):20-6. PubMed ID: 6627901
    [No Abstract]   [Full Text] [Related]  

  • 14. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
    Kovarsky J
    Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276
    [No Abstract]   [Full Text] [Related]  

  • 15. Cellular and humoral immune parameters of synovial fluid and blood in rheumatoid arthritis.
    Dorwart BB; Hebert J; Schumacher HR; Abdou NI
    J Rheumatol; 1975 Dec; 2(4):363-72. PubMed ID: 1082030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of D-penicillamine on the immunological indices of rheumatoid arthritis patients].
    Sheĭtanov I
    Vutr Boles; 1990; 29(4):59-64. PubMed ID: 2281661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte subpopulations in normals and patients with rheumatoid arthritis and ankylosing spondylitis.
    Rosenthal M; Muller W
    J Rheumatol; 1975 Dec; 2(4):355-8. PubMed ID: 1082029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of clinical activity and D-penicillamine or gold treatment on the occurrence of serum immune complexes in patients with rheumatoid arthritis].
    Brühl W; Swierczyńska Z; Cygler B; Woźniczko-Orłowska G
    Reumatologia; 1979; 17(3):303-6. PubMed ID: 515575
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical assessment of the immunoglobulin level in rheumatoid arthritis].
    Ianbaeva KhI; Isakhanov GI; Konstantinovskaia AA
    Ter Arkh; 1982; 54(12):56-8. PubMed ID: 6984236
    [No Abstract]   [Full Text] [Related]  

  • 20. [Laboratory findings in patients with rheumatoid arthritis during D-penicillamine- and goldtherapy (author's transl)].
    Stojan B; Hasler F
    Schweiz Rundsch Med Prax; 1977 Nov; 66(45):1435-6. PubMed ID: 928308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.